{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:24:30Z","timestamp":1774499070664,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:00:00Z","timestamp":1493337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"The Wellcome Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Autoimmun Highlights"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s13317-017-0095-4","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T10:52:06Z","timestamp":1493376726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Induction of IL-10 cytokine and the suppression of T cell proliferation by specific peptides from red cell band 3 and in vivo effects of these peptides on autoimmune hemolytic anemia in NZB mice"],"prefix":"10.1007","volume":"8","author":[{"given":"Abdel-Rahman","family":"Youssef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Elson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"issue":"1","key":"95_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/eji.1830260121","volume":"26","author":"FE Perry","year":"1996","unstructured":"Perry FE, Barker RN, Mazza G, Day MJ, Wells AD, Shen CR, Schofield AE, Elson CJ (1996) Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse. Eur J Immunol 26(1):136\u2013141","journal-title":"Eur J Immunol"},{"issue":"2","key":"95_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2567.1996.d01-731.x","volume":"89","author":"CR Shen","year":"1996","unstructured":"Shen CR, Mazza G, Perry FE, Beech JT, Thompson SJ, Corato A, Newton S, Barker RN, Elson CJ (1996) T-helper 1 dominated responses to erythrocyte Band 3 in NZB mice. Immunology 89(2):195\u2013199","journal-title":"Immunology"},{"issue":"4","key":"95_CR3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4049\/jimmunol.116.4.1051","volume":"116","author":"DH DeHeer","year":"1976","unstructured":"DeHeer DH, Edgington TS (1976) Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice. J Immunol 116(4):1051\u20131058","journal-title":"J Immunol"},{"issue":"7","key":"95_CR4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/eji.1830230750","volume":"23","author":"RN Barker","year":"1993","unstructured":"Barker RN, de S\u00e1 Oliveira GG, Elson CJ, Lydyard PM (1993) Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur J Immunol 23(7):1723\u20131726","journal-title":"Eur J Immunol"},{"issue":"2","key":"95_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2249.1994.tb06557.x","volume":"96","author":"GG Oliveria","year":"1994","unstructured":"Oliveria GG, Hutchings PR, Roitt IM, Lydyard PM (1994) Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies. Clin Exp Immunol 96(2):297\u2013302","journal-title":"Clin Exp Immunol"},{"key":"95_CR6","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.157.6.2676","volume":"157","author":"SY Chen","year":"1996","unstructured":"Chen SY, Takeoka Y, Ansari AA, Boyd R, Klinman DM, Gershwin ME (1996) The natural history of disease expression in CD4 and CD8 gene-deleted New Zealand black (NZB) mice. J Immunol 157:2676\u20132684","journal-title":"J Immunol"},{"issue":"2","key":"95_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/jaut.2001.0579","volume":"18","author":"CR Shen","year":"2002","unstructured":"Shen CR, Ward FJ, Devine A, Luross JA, Lowrey PA, Wraith DC, Elson CJ, Barker RN (2002) Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse. J Autoimmun 18(2):149\u2013157","journal-title":"J Autoimmun"},{"issue":"4","key":"95_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2567.1999.00722.x","volume":"96","author":"CR Shen","year":"1999","unstructured":"Shen CR, Wraith DC, Elson CJ (1999) Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptide. Immunology 96(4):595\u2013599","journal-title":"Immunology"},{"issue":"10","key":"95_CR9","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1182\/blood-2002-07-2125","volume":"102","author":"CR Shen","year":"2003","unstructured":"Shen CR, Youssef AR, Devine A, Bowie L, Hall AM, Wraith DC, Elson CJ, Barker RN (2003) Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia. Blood 102(10):3800\u20133806","journal-title":"Blood"},{"issue":"1","key":"95_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32(1):23\u201363","journal-title":"Crit Rev Immunol"},{"key":"95_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2249.2005.02663.x","volume":"139","author":"AR Youssef","year":"2005","unstructured":"Youssef AR, Shen CR, Lin CL, Barker RN, Elson CJ (2005) IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice. Clin Exp Immunol 139:84\u201389","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"95_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.imlet.2008.11.013","volume":"122","author":"DC Wraith","year":"2009","unstructured":"Wraith DC (2009) Therapeutic peptide vaccines for treatment of autoimmune diseases. Immunol Lett 122(2):134\u2013136","journal-title":"Immunol Lett"},{"issue":"9","key":"95_CR13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/intimm\/5.9.1159","volume":"5","author":"B Metzler","year":"1993","unstructured":"Metzler B, Wraith DC (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 5(9):1159\u20131165","journal-title":"Int Immunol"},{"issue":"10","key":"95_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/intimm\/11.10.1625","volume":"11","author":"C Burkhart","year":"1999","unstructured":"Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC (1999) Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 11(10):1625\u20131634","journal-title":"Int Immunol"},{"issue":"4","key":"95_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/imm.12219","volume":"141","author":"V Holan","year":"2014","unstructured":"Holan V, Zajicova A, Javorkova E, Trosan P, Chudickova M, Pavlikova M, Krulova M (2014) Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells. Immunology 141(4):577\u2013586","journal-title":"Immunology"},{"issue":"6","key":"95_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1365-3083.1996.d01-355.x","volume":"44","author":"S Persson","year":"1996","unstructured":"Persson S, Mikulowska A, Narula S, O\u2019Garra A, Holmdahl R (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44(6):607\u2013614","journal-title":"Scand J Immunol"},{"issue":"2","key":"95_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/clin.1994.1068","volume":"71","author":"KJ Pennline","year":"1994","unstructured":"Pennline KJ, Roque-Gaffney E, Monahan M (1994) Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 71(2):169\u2013175","journal-title":"Clin Immunol Immunopathol"},{"issue":"7","key":"95_CR18","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V90.7.2701","volume":"90","author":"RN Barker","year":"1997","unstructured":"Barker RN, Hall AM, Standen GR, Jones J, Elson CJ (1997) Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia. Blood 90(7):2701\u20132715","journal-title":"Blood"},{"issue":"13","key":"95_CR19","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1182\/blood-2002-05-1383","volume":"100","author":"AM Hall","year":"2002","unstructured":"Hall AM, Ward FJ, Vickers MA, Stott LM, Urbaniak SJ, Barker RN (2002) Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood 100(13):4529\u20134536","journal-title":"Blood"},{"key":"95_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0022-1759(97)00072-0","volume":"205","author":"JT Beech","year":"1997","unstructured":"Beech JT, Bainbridge T, Thompson SJ (1997) Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection. J Immunol Methods 205:163\u2013168","journal-title":"J Immunol Methods"},{"key":"95_CR21","first-page":"9","volume":"1","author":"RC Sheppard","year":"1986","unstructured":"Sheppard RC (1986) Modern methods of solid-phase peptide synthesis. Sci Tools 1:9\u201311","journal-title":"Sci Tools"},{"issue":"6025","key":"95_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/316234a0","volume":"316","author":"RR Kopito","year":"1985","unstructured":"Kopito RR, Lodish HF (1985) Primary structure and transmembrane orientation of the murine anion exchange protein. Nature 316(6025):234\u2013238","journal-title":"Nature"},{"issue":"8899","key":"95_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0140-6736(94)91582-2","volume":"343","author":"D Elias","year":"1994","unstructured":"Elias D, Cohen IR (1994) Peptide therapy for diabetes in NOD mice. Lancet 343(8899):704\u2013706","journal-title":"Lancet"},{"issue":"5","key":"95_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2337\/diab.46.5.758","volume":"46","author":"D Elias","year":"1997","unstructured":"Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, K\u00f6nen-Waisman S, Cohen IR (1997) Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 46(5):758\u2013764","journal-title":"Diabetes"},{"key":"95_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0140-6736(02)09332-7","volume":"360","author":"WL Oldfield","year":"2002","unstructured":"Oldfield WL, Larche M, Kay AB (2002) Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360:47\u201353","journal-title":"Lancet"},{"issue":"6","key":"95_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1067\/mai.2003.1570","volume":"111","author":"JN Francis","year":"2003","unstructured":"Francis JN, Till SJ, Durham SR (2003) Induction of IL-10+ CD4+ CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111(6):1255\u20131261","journal-title":"J Allergy Clin Immunol"},{"issue":"4 Suppl","key":"95_CR27","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1038\/nm1226","volume":"11","author":"M Larche","year":"2005","unstructured":"Larche M, Wraith DC (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 11(4 Suppl):S69\u2013S76","journal-title":"Nat Med"},{"issue":"1","key":"95_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1084\/jem.184.1.19","volume":"184","author":"H Groux","year":"1996","unstructured":"Groux H, Bigler M, de Vries JE, Roncarolo MG (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184(1):19\u201329","journal-title":"J Exp Med"},{"issue":"9","key":"95_CR29","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.4049\/jimmunol.165.9.4848","volume":"165","author":"F Cottrez","year":"2000","unstructured":"Cottrez F, Hurst SD, Coffman RL, Groux H (2000) T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 165(9):4848\u20134853","journal-title":"J Immunol"},{"issue":"1\u20132","key":"95_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2006.05.030","volume":"178","author":"EJ O\u2019Neill","year":"2006","unstructured":"O\u2019Neill EJ, Day MJ, Wraith DC (2006) IL-10 is essential for disease protection following intranasal peptide administration in the C57BL\/6 model of EAE. J Neuroimmunol 178(1\u20132):1\u20138","journal-title":"J Neuroimmunol"},{"issue":"6","key":"95_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/eji.1830240629","volume":"24","author":"O Rott","year":"1994","unstructured":"Rott O, Fleischer B, Cash E (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24(6):1434\u20131440","journal-title":"Eur J Immunol"},{"key":"95_CR32","doi-asserted-by":"publisher","first-page":"944e7","DOI":"10.1126\/science.3107127","volume":"236","author":"CM Snapper","year":"1987","unstructured":"Snapper CM, Paul WE (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944e7","journal-title":"Science"},{"key":"95_CR33","doi-asserted-by":"publisher","first-page":"303e33","DOI":"10.1146\/annurev.iy.08.040190.001511","volume":"8","author":"FD Finkelman","year":"1990","unstructured":"Finkelman FD, Holmes J, Katona IM et al (1990) Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8:303e33","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"95_CR34","doi-asserted-by":"publisher","first-page":"e0113963","DOI":"10.1371\/journal.pone.0113963","volume":"10","author":"W Wodal","year":"2015","unstructured":"Wodal W, Schwendinger MG, Savidis-Dacho H et al (2015) Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs. PLoS One 10(2):e0113963","journal-title":"PLoS One"},{"issue":"6","key":"95_CR35","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/md9061038","volume":"9","author":"ZS Wen","year":"2011","unstructured":"Wen ZS, Xu YL, Zou XT, Xu ZR (2011) Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Mar Drugs 9(6):1038\u20131055","journal-title":"Mar Drugs"},{"issue":"5","key":"95_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1046\/j.1365-2222.2002.01391.x","volume":"32","author":"JM Smart","year":"2002","unstructured":"Smart JM, Kemp AS (2002) Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy 32(5):796\u2013802","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"95_CR37","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0022-3476(05)82182-1","volume":"118","author":"CB Wilson","year":"1991","unstructured":"Wilson CB (1991) The ontogeny of T lymphocyte maturation and function. J Pediatr 118(3):S4\u2013S9","journal-title":"J Pediatr"}],"container-title":["Autoimmunity Highlights"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13317-017-0095-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13317-017-0095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13317-017-0095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T09:49:01Z","timestamp":1692784141000},"score":1,"resource":{"primary":{"URL":"https:\/\/autoimmunhighlights.biomedcentral.com\/articles\/10.1007\/s13317-017-0095-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["95"],"URL":"https:\/\/doi.org\/10.1007\/s13317-017-0095-4","relation":{},"ISSN":["2038-0305","2038-3274"],"issn-type":[{"value":"2038-0305","type":"print"},{"value":"2038-3274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]},"assertion":[{"value":"8 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research does not involve human subjects, human materials. All animal experiments complied with UK Home office regulations, and the \u2018Principles of laboratory animal care\u2019 were followed throughout.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and animal rights"}}],"article-number":"7"}}